The study involved two major activities in estimating the current size of the depth filtration market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Secondary Research;

In the secondary research process, various sources, such as Hoovers, Bloomberg Business Week, Forbes, and Dun & Bradstreet, were referred to for identifying and collecting information useful for this study. Some of the secondary sources used for this study include annual reports, press releases, investor presentations of companies, World Bank, International Society for Pharmaceutical Engineering (ISPE), Bio-Process Systems Alliance (BPSA), US Food and Drug Administration (US FDA), American Filtration and Separations Society (AFS), American Membrane Technology Association,(AMTA), Indian Pharmaceutical Association, Parenteral Drug Association (PDA).

According to the new market research report “Depth Filtration Market by Media Type (Cellulose, Activated Carbon), Product (Capsule, Sheet, Module), Application(Final Product Processing (Biologics), cell Clarification, Viral Clearance, Operation Scale (Manufacturing, Lab) – Global Forecast to 2025” published by MarketsandMarkets™.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=143876285

Expected Revenue Surge: The global depth filtration market is projected to reach USD 2.9 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 9.0% during the forecast period.

Geographical Scenario in Depth:

Segmented into four major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle-East & Africa. In 2019, North America accounted for the largest share of 38.0% of the global depth filtration market, followed by Europe, with a share of 29.2%. The large share of the North American region can be attributed to a large number of pharmaceutical and biotechnology companies in the region and the presence of a well-established healthcare market.

The Asia Pacific market, on the other hand, is expected to register the highest growth during the forecast period. Factors such as increasing research and development by pharmaceutical companies in China, India, and Japan are likely to support the growth of this market.

Leading Key-Players:

The major companies operating in the global depth filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), 3M (US), Parker Hannifin Corporation (US), Porvair Filtration Group (UK), ErtelAlsop (US), Amazon Filters Ltd. (UK), Meissner Filtration Products, Inc. (US), Donaldson Comany, Inc. (US), Eaton Corporation (Ireland), Saint-Gobain Performance Plastics (France), Clariance Technique (Australia), Repligen Corporation (US), Microfilt India Pvt. Ltd. (India), Graver Technologies (US), Gusmer Enterprises (US), Filtrox AG (Switzerland), Pure Process (UK), Membrane Solutions (US), Allied Filter Systems Ltd. (UK), Pentair (US), Membracon (UK), and Phenomenex (US)

Danaher Corporation (US) is the leading player in the global depth filtration market owing to its broad range of products in depth filtration. The sale of the company’s separation, filtration, and purification technologies have witnessed high demand from the biopharmaceutical industry in Western Europe, North America, and other high-growth markets, particularly in the Asia Pacific region. The company is focusing on expanding its presence in Europe and the Asia Pacific region to maintain its leadership position.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143876285

Recent Developments in Depth Filtration Market:

– In 2019, Sartorius opened manufacturing operations in Yauco, Puerto Rico, to increase its production capacity and deliver a wider array of products to its American customers directly.

– In 2019, Merck expanded its distribution capacity in Gillingham, UK.

– In 2019, Parker Bioscience Filtration, a part of Parker Hannifin, expanded its facilities at Birtley, UK